Bettina Hamelin’s Post

View profile for Bettina Hamelin, graphic

President at Innovative Medicines Canada

I am extremely passionate about drug discovery, development and commercialization of innovation. That is what both the innovative pharmaceutical industry and Canada’s life sciences sector do! It is only by working together across the sector and with government that we can move the needle on industrial and access policies that turn Canada into a G7 leader where investments into innovation and access to these innovations go hand in hand. #HESA #collaboration #HealthyCanadians #healthyeconomy #healthyplanet Innovative Medicines Canada - Médicaments novateurs Canada

IMC is pleased to share its comments on Bill C-64, An Act respecting #pharmacare, with members of the Standing Committee on Health. We must ensure that any pharmacare program elevates access to innovative medicines to improve the health and well-being of all Canadians.   To accomplish this, pharmacare must build on Canada's extensive existing public and employer-sponsored drug plans rather than replace them with more restrictive public formularies. The limited available funding should address unique coverage gaps in consultation with the provinces and territories.   By working together, we can create a modern, agile, and practical pharmacare program with life-changing impacts for generations to come.   Read more in our detailed submission: https://lnkd.in/gttJG2jC Bettina Hamelin #HESA ------------------------------------------------------------------------------------ Médicaments novateurs Canada est ravie de faire part de ses commentaires sur le projet de loi C-64 concernant l’#assurancemédicaments aux membres du Comité permanent de la santé. Nous devons veiller à ce que tout programme d’assurance médicaments rehausse le niveau d’accès aux nouveaux médicaments novateurs afin d’améliorer la santé et le bien-être de toute la population canadienne.   Pour ce faire, il faut s’appuyer sur les vastes régimes publics et offerts par l’employeur existants au Canada, plutôt que de les remplacer par des régimes publics plus restrictifs. Les fonds limités disponibles doivent servir à combler les lacunes uniques de la couverture en consultation avec chaque gouvernement.   En travaillant ensemble, nous pouvons créer un programme d’assurance médicaments moderne, flexible et pratique qui aura une incidence positive sur la vie des prochaines générations.   Pour en savoir plus, consultez notre mémoire détaillé : https://lnkd.in/gEUdR8e2

Rudy Fernandes

President at Global Health Strategy Inc.

6mo

Canadians have benefitted over the years from the passion and contributions of the innovative research-based pharmaceutical companies, in close partnership with Innovative Medicines Canada (IMC), in key areas of drug discovery, development and the commercialization of innovation. Such focused efforts have led to many significant contributions, by our innovative medicines sector, towards the enhancement of healthcare outcomes. I fully agree with the IMC President that "it is only by working together across the sector, and with government, that we can move the needle on industrial and access policies that turn Canada into a G7 leader.” We can only achieve a Win-Win outcome when "investments into innovation, and access to these innovations, go hand in hand".

Like
Reply

To view or add a comment, sign in

Explore topics